PACS CORE/ENCORE™ is a software device that receives digital images and data from various sources (such as, CT scanners, MR scanners, ultrasound systems, R/F units, computer and direct radiographic devices, secondary capture devices, scanners, imaging gateways, or other imaging sources). Images and data can be communicated, processed, manipulated, enhanced, stored, and displayed within the system and/or across computer networks at distributed locations. Post-processing of the images can be performed using Multi Planar Reconstruction (MPR). Lossy compressed mammographic images and digitized film screen images must not be reviewed for primary image interpretation. Mammographic images may only be interpreted using a monitor that meets technical specifications identified by FDA. Typical users of this system are trained professionals, physicians, nurses, and technicians.

Device Description

The PACS CORE/ENCORE™ system is a PACS workstation capable of receiving DICOM 3.1 medical images. The System allows displaying studies that are not in the same place where the system is placed. With its Web features, it is possible to review, modify, and approve studies located in a server. General features are as follows:

Integration to PACS systems and inter-connectivity with DICOM stations.
Performing queries to storage systems in other workstations and/or servers to retrieve DICOM studies or images.
Image printing in Windows and DICOM printers.
Selecting and ordering patient lists by date, study, name, gender or ID number.
Importing and exporting images to DVD or CDROM in the following modes: DICOM DIR, DICOM files, JPEG or BMP.
Importing NON-DICOM images to DICOM 3.0 format.
Transfer of studies, images and reports via e-mail.
Study Visualization by series.
Cine feature.
3D reconstruction allowing: MPR (Multiplane Reconstruction) .
Integrated report feature with transcription through pre-set templates, digital dictation, and voice recognition.
Possibility to integrate with a Radiology Information System (RIS).
Work list follow-up; dictated study, transcribed study, and authorized study.
Due to its Web features, it is possible to review, change and approve studies remotely.
Complete Web Windows Presentation Foundation (XBAP) technology application.
Windows Presentation Foundation desk application.

AI/ML Overview

This document pertains to the FDA 510(k) premarket notification K161518 for the PACS CORE/ENCORE™ system, a Picture Archiving Communications System. Based on the provided text, the device is a PACS workstation for receiving, processing, manipulating, enhancing, storing, and displaying digital medical images and data.

The FDA 510(k) submission for PACS CORE/ENCORE™ focuses on demonstrating substantial equivalence to an existing predicate device rather than presenting a novel clinical study with specific acceptance criteria related to diagnostic performance metrics (e.g., sensitivity, specificity for disease detection). The core of the evaluation revolves around the software's functionality and safety as a medical image management system.

Therefore, the requested information needs to be interpreted within the context of a PACS system's validation for substantial equivalence, which primarily involves functional testing and safety assessments.

Here's an attempt to extract and infer the information based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

Since this is a PACS system and the submission is focused on substantial equivalence based on functional and safety requirements, the acceptance criteria are related to the system's ability to perform its stated functions without significant failures, rather than clinical performance metrics.

Acceptance Criteria	Reported Device Performance
Functional Requirements Met: The device performs all required actions according to the Software Requirements Specification (SRS) and User Manual.	The device has passed all in-house pre-determined testing criteria. The data demonstrates that PACS CORE/ENCORE™ performs all required actions according to the functional requirements specified in the SRS and the User Manual.
Safety and Efficacy: No errors with an impact on safety or efficacy.	No errors that had an impact on safety or efficacy were found during testing.
Integration with DICOM Systems: Ability to receive DICOM 3.1 medical images and integrate withPACS systems and other DICOM stations.	The PACS CORE/ENCORE™ system is a PACS workstation capable of receiving DICOM 3.1 medical images. It offers "Integration to PACS systems and inter-connectivity with DICOM stations."
Image Display & Manipulation: Capability to display studies, perform MPR, Cine feature, 3D reconstruction.	The system allows displaying studies, offers Cine feature, and 3D reconstruction allowing MPR.
Data Management: Performing queries, importing/exporting images, transferring studies/images/reports.	The system can perform queries to storage systems, import/export images (DVD/CDROM, DICOM DIR, DICOM files, JPEG, BMP), and transfer studies/images/reports via e-mail.
Reporting Capabilities: Integrated report feature with transcription, digital dictation, and voice recognition.	Offers "Integrated report feature with transcription through pre-set templates, digital dictation, and voice recognition."
Remote Access: Web features for reviewing, modifying, and approving studies remotely.	"With its Web features, it is possible to review, modify, and approve studies located in a server." and "Due to its Web features, it is possible to review, change and approve studies remotely."
Hazard Analysis: "Level of Concern for potential hazards has been classified as "Moderate"."	The submission contains the results of a hazard analysis and the "Level of Concern for potential hazards has been classified as "Moderate"."

2. Sample Size Used for the Test Set and the Data Provenance

The document states, "The complete system configuration has been tested at the factory and the device has passed all in-house pre-determined testing criteria without significant failures."

Sample Size: The text does not specify a numerical sample size for the test set (e.g., number of images, number of cases). The testing appears to be functional and system-level validation rather than a clinical study evaluating diagnostic accuracy on a specific number of patient cases.
Data Provenance: The text does not explicitly state the country of origin or whether the data was retrospective or prospective. Given it's "in-house pre-determined testing criteria," it likely involves a combination of simulated data, test data, and potentially a limited set of real patient images for functional verification within a controlled environment, rather than a large-scale clinical dataset.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts

This type of information is typically not applicable to the validation of a PACS system for substantial equivalence by the FDA. PACS systems are image management tools, and their "ground truth" during testing is typically whether they correctly display, process, store, and transmit images according to technical specifications. It does not involve expert readers establishing a diagnostic ground truth for disease states. Therefore, the document does not mention experts establishing ground truth for a test set.

4. Adjudication Method for the Test Set

Not applicable for this type of system validation. Adjudication methods (like 2+1, 3+1) are used in clinical studies where there's disagreement among human readers interpreting medical images to establish a consensus ground truth. This is not described for the PACS CORE/ENCORE™ testing.

5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was Done

No, a Multi Reader Multi Case (MRMC) comparative effectiveness study was not done. Such studies compare the diagnostic performance of human readers with and without AI assistance or different devices. This FDA submission is for a PACS system, which is a foundational imaging infrastructure tool, not a diagnostic AI algorithm.

6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was Done

No, an algorithm-only (standalone) performance study was not done. The PACS CORE/ENCORE™ is a system for managing and displaying images, not a standalone diagnostic algorithm. The indications for use explicitly state that "A physician, providing ample opportunity for competent human intervention interprets images and information being displayed and printed," confirming a human-in-the-loop approach for image interpretation.

7. The Type of Ground Truth Used

The "ground truth" for the PACS CORE/ENCORE™ system's testing would be:

Functional Specifications: Whether the system correctly performs each function as defined in its Software Requirements Specification (SRS) and User Manual (e.g., Does it display the image correctly? Does MPR work as expected? Can it query the archive?).
Technical Compliance: Adherence to standards like DICOM 3.1 for image handling and communication.
Safety Requirements: Absence of errors that compromise patient safety or data integrity.

It is not a clinical ground truth like pathology, expert consensus on disease, or patient outcomes data.

8. The Sample Size for the Training Set

The document does not mention a "training set" because PACS CORE/ENCORE™ is not an AI/Machine Learning diagnostic device that requires a training set. The system is validated based on its adherence to functional and safety requirements, not by learning from a dataset.

9. How the Ground Truth for the Training Set Was Established

Not applicable, as there is no training set for this type of device.

Summary

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged in a circular fashion around the symbol. The caduceus is depicted in black, and the text is also in black.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

August 17, 2016

COMPAÑÍA MEXICANA DE RADIOLOGÍA CGR, S.A. de C.V. % Mr. Carl Alletto Consultant OTech Inc. 8317 Belew Drive MCKINNEY TX 75071

Re: K161518

Trade/Device Name: PACS CORE/ENCORE™ Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: June 18, 2016 Received: June 21, 2016

Dear Mr. Alletto:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

Michael D'Hara

For

Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K161518

Device Name PACS CORE/ENCORE™

Indications for Use (Describe)

Type of Use (Select one or both, as applicable)
-------------------------------------------------

X Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

This 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990.

Date Prepared:

May 23, 2016

Submitter's Information: 21 CFR 807.92(a)(1) Mr. Carl Alletto 8317 Belew Drive McKinney TX, 75071 USA Email: carl@otechimq.com Phone: +1 469.684.1980

Trade Name, Common Name and Classification: 21 CFR 807.92(a)(2)

Trade Name:	PACS CORE/ENCORE™
Common Name:	Picture Archiving Communications System
Device Classification:	892.2050 System, Image Processing
Product Code:	LLZ

Predicate Device: 21 CFR 807. 92(a)(3)

Device Classification Name	system, image processing, radiological
510(k) Number	K092949
Device Name	IMAGEGRID RADIOLOGY VIEWER SYSTEM
Regulation Number	892.2050
Classification Product Code	LLZ
Date Received	09/24/2009
Decision Date	10/08/2009
Decision	substantially equivalent (SESE)
Regulation Medical Specialty	Radiology
510k Review Panel	Radiology
summary	summary
Type	Traditional
Combination Product	No

Device Description: 21 CFR 807 92(a)(4)

Integration to PACS systems and inter-connectivity with DICOM stations. ●
. Performing queries to storage systems in other workstations and/or servers to retrieve DICOM studies or images.

{4}------------------------------------------------

Image printing in Windows and DICOM printers. ●
. Selecting and ordering patient lists by date, study, name, gender or ID number.
Importing and exporting images to DVD or CDROM in the following modes: ● DICOM DIR, DICOM files, JPEG or BMP.
. Importing NON-DICOM images to DICOM 3.0 format.
. Transfer of studies, images and reports via e-mail.
Study Visualization by series.
Cine feature. ●
3D reconstruction allowing: MPR (Multiplane Reconstruction) .
Integrated report feature with transcription through pre-set templates, digital dictation, and voice recognition.
Possibility to integrate with a Radiology Information System (RIS). ●
Work list follow-up; dictated study, transcribed study, and authorized study.
Due to its Web features, it is possible to review, change and approve studies ● remotely.
. Complete Web Windows Presentation Foundation (XBAP) technology application.
. Windows Presentation Foundation desk application.

Indications for Use: 21 CFR 807 92(a)(5)

PACS CORE/ENCORE™ is a software device that receives digital images and data from various sources (such as, CT scanners, MR scanners, ultrasound systems. R/F units, computer and direct radiographic devices, secondary capture devices, scanners, imaging gateways, or other imaging sources). Images and data can be communicated, processed, manipulated, enhanced, stored, and displayed within the system and/or across computer networks at distributed locations. Post-processing of the images can be performed using Multi Planar Reconstruction (MPR).

Lossy compressed mammographic images and digitized film screen images must not be reviewed for primary image interpretation. Mammographic images may only be interpreted using a monitor that meets technical specifications identified by FDA. Typical users of this system are trained professionals, physicians, nurses, and technicians.

Technological Characteristics: 21 CFR 807 92(a)(6)

PACS CORE/ENCORE™ device is a software product that handles digital medical images. The device does not contact the patient, nor does it control any life sustaining devices. A physician, providing ample opportunity for competent human intervention interprets images and information being displayed and printed.

Testing

{5}------------------------------------------------

510(k) Summary of Safety and Effectiveness

The complete system configuration has been tested at the factory and the device has passed all in-house pre-determined testing criteria without significant failures. The data presented in the submission demonstrates that PACS CORE/ENCORE™ performs all required actions according to the functional requirements specified in the SRS and the User Manual with no errors that had an impact on safety or efficacy.

Conclusion: 21 CFR 807 92(b)(1)

The 510 (k) Pre-Market Notification PACS CORE/ENCORE™ contains adequate information and data to enable FDA - CDRH to determine substantial equivalence to the predicate device. PACS CORE/ENCORE™ has been and will be manufactured in accordance with the voluntary standards listed in the enclosed voluntary standard survey. The submission contains the results of a hazard analysis and the "Level of Concern for potential hazards has been classified as "Moderate".

Regulation Number and Section

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).